Citation Impact
Citing Papers
Tumor Cell–Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells
2016
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Colorectal cancer statistics, 2020
2020 Standout
Cancer statistics, 2022
2022 Standout
Laparoscopic Radical Hysterectomy in Early Stage Cervical Cancer: A Systematic Review and Meta-Analysis
2017
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Colorectal cancer statistics, 2023
2023 Standout
Cancer statistics, 2023
2023 Standout
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis
2003 Standout
Controlling timing and location in vaccines
2020
Head and neck squamous cell carcinoma
2020 Standout
Breast-cancer detection using blood-based infrared molecular fingerprints
2021 StandoutNobel
Cancer statistics, 2020
2020 Standout
Cancer statistics, 2024
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Cancer statistics, 2019
2019 Standout
Cancer statistics, 2018
2018 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Cancer Statistics, 2021
2021 Standout
Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
2014
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Targeting natural killer cells and natural killer T cells in cancer
2012
Cost-effectiveness studies of HPV self-sampling: A systematic review
2020
Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma
2013
The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1 −/− murine model of ovarian cancer
2015
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Pancreatic cancer
2020 Standout
Ovarian cancer
2014 Standout
Transforming Growth Factor-β Signaling in Immunity and Cancer
2019 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Geographic and sociodemographic differences in cervical cancer screening modalities
2020
Attitudes to vaccination: A critical review
2014 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments
2017
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
2015
A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability
2010
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
The causal relation between human papillomavirus and cervical cancer
2002 Standout
Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
2013
A survey on deep learning in medical image analysis
2017 Standout
Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome
2018
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Papillomavirus E5: the smallest oncoprotein with many functions
2011
Interferons and viruses: an evolutionary arms race of molecular interactions
2015 StandoutNobel
Cancer screening in the United States, 2013
2013
Applications of CRISPR technologies in research and beyond
2016 StandoutNobel
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
2013 Standout
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
2017
Recent progress in the diagnosis and treatment of ovarian cancer
2011
Digital pathology and artificial intelligence
2019 Standout
Lymphedema beyond breast cancer
2010 Standout
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
NK cell-based immunotherapy for malignant diseases
2013
Review of deep learning: concepts, CNN architectures, challenges, applications, future directions
2021 Standout
Artificial Intelligence and COVID-19: Deep Learning Approaches for Diagnosis and Treatment
2020
Robotic radical hysterectomy in early stage cervical cancer: A systematic review and meta-analysis
2015
Cervical cancer
2019 Standout
Small Interfering RNA for Effective Cancer Therapies
2011
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
2015 Standout
Hepatocellular carcinoma
2022 Standout
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix
2009
The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)
2011
Liposomal Bupivacaine: A Review and Applications to Dermatologic Surgery
2018
Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening
2016
Comparison of the long‐term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study
2020
Multiple Human Papilloma Virus Infections and Their Impact on the Development of High-Risk Cervical Lesions
2015
The MAPK pathway across different malignancies: A new perspective
2014 Standout
Racial and Ethnic Differences in Hysterectomy-Corrected Uterine Corpus Cancer Mortality by Stage and Histologic Subtype
2022
Breast Cancer Statistics, 2022
2022 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
Accurate Cervical Cell Segmentation from Overlapping Clumps in Pap Smear Images
2016
TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells
2014
Cancer statistics for Hispanics/Latinos, 2015
2015
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
Updated Review of Major Cancer Risk Factors and Screening Test Use in the United States in 2018 and 2019, with a Focus on Smoking Cessation
2021
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
2020
Cancer treatment and survivorship statistics, 2016
2016 Standout
Accurate Segmentation of Cervical Cytoplasm and Nuclei Based on Multiscale Convolutional Network and Graph Partitioning
2015
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer
2018 Standout
Recent progress in the treatment and prevention of cancer‐related lymphedema
2014
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Global cancer statistics, 2012
2015 Standout
Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting
2013
Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening
2018
Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer
2011
Works of Levi S. Downs being referenced
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
2012
Ultrasound guided subcostal transversus abdominis plane (TAP) infiltration with liposomal bupivacaine for patients undergoing robotic assisted hysterectomy: A prospective randomized controlled study
2015
A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer
2009
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer
2012
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
2010
Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers
2010
Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer
2008
The disparity of cervical cancer in diverse populations
2008
A prospective, randomized study analyzing sartorius transposition following inguinal–femoral lymphadenectomy
2004
A prospective randomized trial of thalidomide with topotecan compared with topotecan alone in women with recurrent epithelial ovarian carcinoma
2007
Receipt of adjuvant endometrial cancer treatment according to race: an NRG Oncology/Gynecologic Oncology Group 210 Study
2018
Multiple-Type Human Papillomavirus (HPV) Infections
2013
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
2012
Positron emission tomography and leiomyomas: Clinicopathologic analysis of 3 cases of PET scan-positive leiomyomas and literature review
2006
Initial lessons learned in HPV vaccination
2008
Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study
2017